跳至主要内容
临床试验/EUCTR2010-022472-31-GB
EUCTR2010-022472-31-GB进行中(未招募)不适用

The effect of Lidocaine and its Delivery in Patients with Chronic Cough - Lidocaine: Effect of Lidocaine in Chronic Cough

niversity Hospital of South Manchester0 个研究点目标入组 0 人开始时间: 2010年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Male and female subjects, age 18 years and over. - History of cough for more than 8 weeks. - Normal chest x ray. - Chronic idiopathic cough or chronic cough resistant to treatment of specific triggers.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range
  • - Male and female subjects, age 18 years and over. - History of cough for more than 8 weeks. - Normal chest x ray. - Chronic idiopathic cough or chronic cough resistant to treatment of specific triggers.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • SMOKING STATUS: - Current smokers - Ex smokers with history of smoking > 20 pack years or those who have given up < 6 months ago. PROHIBITED MEDICATIONS: - Use of medications likely to suppress / affect cough including codeine, morphine, pregabalin, gabapentin, amitriptylline, angiotensin convertin enzyme inhibitors (type 1) and baclofen. - Use of any anti-arrhythmic medication. - Use of cimetidine, beta blockers, or diuretics. CARDIOVASCULAR CONDITIONS: - Sinoatrial disease, bradycardia or all types of heart blocks. - History of ischaemic heart disease or heart failure. - Clinically significant abnormal electrocardiogram (ECG) at Screening or Baseline. - History of cardiac surgery RESPIRATORY CONDITIONS: - Asthma. CENTRAL/PERIPHERAL NERVOUS SYSTEM CONDITIONS: - Epilepsy. - Myasthenia gravis. MISCELLANEOUS: - History of hepatic or renal dysfunction. - Porphyria - History of hypersensitivity to Lidocaine or related drugs. - Pregnancy or breast feeding. - Participation in another trial within the preceding 6 weeks. - Trauma or ulceration to oral mucosa. - History of chest or upper airway infection within the past 6 weeks. - Conditions which may affect cough response such as stroke, diabetes, Parkinson’s disease.
  • SMOKING STATUS: - Current smokers - Ex smokers with history of smoking > 20 pack years or those who have given up < 6 months ago. PROHIBITED MEDICATIONS: - Use of medications likely to suppress / affect cough including codeine, morphine, pregabalin, gabapentin, amitriptylline, angiotensin convertin enzyme inhibitors (type 1) and baclofen. - Use of any anti-arrhythmic medication. - Use of cimetidine, beta blockers, or diuretics. CARDIOVASCULAR CONDITIONS: - Sinoatrial disease, bradycardia or all types of heart blocks. - History of ischaemic heart disease or heart failure. - Clinically significant abnormal electrocardiogram (ECG) at Screening or Baseline. - History of cardiac surgery RESPIRATORY CONDITIONS: - Asthma. CENTRAL/PERIPHERAL NERVOUS SYSTEM CONDITIONS: - Epilepsy. - Myasthenia gravis. MISCELLANEOUS: - History of hepatic or renal dysfunction. - Porphyria - History of hypersensitivity to Lidocaine or related drugs. - Pregnancy or breast feeding. - Participation in another trial within the preceding 6 weeks. - Trauma or ulceration to oral mucosa. - History of chest or upper airway infection within the past 6 weeks. - Conditions which may affect cough response such as stroke, diabetes, Parkinson’s disease.

研究者

发起方
niversity Hospital of South Manchester

相似试验